2024年国际卵泡淋巴瘤科学研讨会的共识建议
Reid W Merryman1, Sarah C Rutherford2, Stephen M Ansell3
1Dana Farber Cancer Institute, Boston, Massachusetts, United States.
Blood advances
|December 3, 2025
概括
毛囊性淋巴瘤 (FL) 患者经常发展出耐药性疾病,尽管最初的治疗成功. 专家们讨论了新疗法,治疗顺序和了解FL生物学,以改善结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 毛囊性淋巴瘤 (FL) 是最常见的惰性非霍奇金淋巴瘤.
- 虽然初始治疗响应率很高,但抗病性和转化为攻击性淋巴瘤存在重大挑战.
- 目前的治疗策略需要改进,以与FL生物学和患者特异性疾病进展的不断变化的理解保持一致.
研究的目的:
- 总结淋巴瘤研究基金会2024年毛囊淋巴瘤科学研讨会的主要讨论.
- 突出FL生物学,第一线治疗策略和早期进展的临床意义 (POD24) 的最新情况.
- 探索临床试验中的新型终点,以及重新定义FL治疗的潜力.
主要方法:
- 在半年一次的科学研讨会上,专家达成共识并进行讨论.
- 审查当前的临床数据和新兴的治疗药物.
- 专注于治疗顺序的挑战,并与瘤生物学调整疗法.
主要成果:
- 新型药物显示了FL治疗早期临床数据令人鼓舞.
- 24个月内疾病的进展 (POD24) 是影响治疗顺序和结果的关键因素.
- 了解FL生物学和瘤微环境的进展对于开发新疗法至关重要.
结论:
- 与瘤生物学结合治疗和优化治疗序列是管理FL的关键挑战.
- 新型药物的开发和精细的临床试验设计对于改善患者的治疗结果至关重要.
- 重新定义FL的治疗需要一个全面的方法,整合生物学,治疗顺序和患者特定因素.
相关概念视频
01:16Primary Lymphoid Organs
14.5K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
14.5K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K